AIG
54
-5
GOOGL
50
-3
MDLZ
32
-4
SLB
42
3
WU
1
-9
NSC
60
-5
MCO
62
-3
LEG
33
-7
MAC
44
-6
NRG
52
-2
RSG
62
-3
ISRG
57
-2
HST
22
-5
CAT
46
-4
EXPE
56
-8
TDC
50
-5
PBI
46
-4
HPQ
21
-4
VMC
53
-4
NI
75
-2
AIG
54
-5
GOOGL
50
-3
MDLZ
32
-4
SLB
42
3
WU
1
-9
NSC
60
-5
MCO
62
-3
LEG
33
-7
MAC
44
-6
NRG
52
-2
RSG
62
-3
ISRG
57
-2
HST
22
-5
CAT
46
-4
EXPE
56
-8
TDC
50
-5
PBI
46
-4
HPQ
21
-4
VMC
53
-4
NI
75
-2
Financhill
Back

Castle Biosciences 10K Form

Sell
42

CSTL
Castle Biosciences

Last Price:
$18.77
Seasonality Move:
27.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-09 10Q CSTL/Castle Biosciences Quarterly
2020-08-10 10Q CSTL/Castle Biosciences Quarterly
2020-05-11 10Q CSTL/Castle Biosciences Quarterly
2020-03-10 10K CSTL/Castle Biosciences Annual
2019-11-12 10Q CSTL/Castle Biosciences Quarterly
2019-09-03 10Q CSTL/Castle Biosciences Quarterly

Receive CSTL News And Ratings

See the #1 stock for the next 7 days that we like better than CSTL

CSTL Financial Statistics

Sales & Book Value

Annual Sales: $332.1M
Cash Flow: $-10.8M
Price / Cash Flow: 13.16
Annual Sales: $15.26
Price / Book: 1.23

Profitability

EPS (TTM): -0.19000
Net Income (TTM): $-5.1M
Gross Margin: $271.9M
Return on Equity: -1.17%
Return on Assets: -1.02%

Castle Biosciences Earnings Forecast

Key Castle Biosciences Financial Ratios

  • The Gross Profit Margin over the past 8 years for CSTL is 81.87%.
  • The Selling, General & Administrative Expenses for CSTL have been equal to 60.24% of Gross Profit Margin.
  • The Research & Development expenses have been 15.67% of Revenue.
  • The Interest Expense is 3.16% of Operating Income.
  • The Net Earning history of CSTL is 5.49% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Castle Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CSTL
CUSIP: 14843C
Website: castlebiosciences.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 9.37
Quick Ratio: 8.89

Price-to-Earnings

Trailing P/E Ratio: 30.24
Forward P/E Ratio: 0

CSTL Technical Analysis vs Fundamental Analysis

Sell
42
Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences a Buy or a Sell?